AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CSL LIMITED

153.270

-0.920-0.60%

Volume:1.46M

Turnover:240.92M

Market Cap:74.36B

PE:37.86

High:154.100

Open:152.550

Low:150.800

Close:154.190

52wk High:272.649

52wk Low:149.850

Shares:485.15M

Float Shares:483.95M

Volume Ratio:1.05

T/O Rate:0.30%

Dividend:4.14

Dividend Rate:2.70%

EPS(TTM):4.049

EPS(LYR):8.741

ROE:6.66%

ROA:6.58%

PB:2.81

PE(LYR):17.54

Loading ...

Overview Company News Filings

CSL Ltd-Change of Director's Interest Notice

THOMSON REUTERS

BUZZ-Australia's CSL recovers after signing licensing deal with Eli Lilly

BRIEF-CSL And Lilly Enter Licensing Agreement For Clazakizumab

CSL Ltd - CSL Will Receive an Upfront Payment of $100 Mln

THOMSON REUTERS

CSL Ltd - Exclusive Licensing Agreement Granting Certain Rights to Develop and Commercialise Clazakizumab

THOMSON REUTERS

CSL's (ASX:CSL) Soft Earnings Are Actually Better Than They Appear

Simply Wall St.

CSL Limited Receives Australian Approval for Neffy Adrenaline Nasal Spray

CSL Ltd - Neffy, Adrenaline Nasal Spray, NOW Approved to Treat Anaphylaxis in Australia

THOMSON REUTERS

CSL (ASX:CSL) Is Down 16.9% After CEO Exit And Profit Hit Has The Bull Case Changed?

Simply Wall St.

CSL (ASX:CSL) Valuation After Profit Slump CEO Exit And Expanded Share Buyback Program

Simply Wall St.

Weekly Earnings Wrap: CBA, CSL, MQG and more

Morning Star AU

BUZZ-CSL rout extends into sixth session after CEO departure, weak earnings

Stock Track | CSL Plummets 7.73% Intraday on Margin Compression and Earnings Concerns

Analysts Are Bullish on These Healthcare Stocks: Viking Therapeutics (VKTX), CSL (CMXHF)

CSL (ASX:CSL) Trailing Net Margin Compression Tests Bullish Growth Narratives

Simply Wall St.

GLOBAL MARKETS-Stocks, dollar jump after US jobs data beat; AI worries simmer below the surface

Australian shares reclaim 9,000 mark as banks rally on CBA results

GLOBAL MARKETS-Buoyant stocks pause for breath; yen gallops higher

CSL's Fiscal H1 EBIT Boosted by Cost Reductions, Jarden Says

MT Newswires Live

ASX Midday Sector Update: Financial Shares Jump, Healthcare Shares Fall

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CSL.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CSL.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CSL.AU\",,,,,undefined,":{"symbol":"CSL.AU","market":"AU","secType":"STK","nameCN":"CSL LIMITED","latestPrice":153.27,"timestamp":1771564320000,"preClose":154.19,"halted":0,"volume":1455538,"delay":0,"changeRate":-0.00596666450483162,"nameEN":"CSL LIMITED","floatShares":483950454,"shares":485151394,"eps":4.048689891995421,"marketStatus":"Market Closed","change":-0.92,"latestTime":"02-20 16:12:00 AEDT","open":152.55,"high":154.1,"low":150.8,"amount":240922095,"amplitude":0.021402,"askPrice":154,"askSize":280,"bidPrice":153,"bidSize":844,"shortable":3,"etf":0,"ttmEps":4.048689891995421,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1771801200000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":154.19,"dividendRate":0.026971,"openAndCloseTimeList":[[1771542000000,1771563600000]],"volumeRatio":1.046357,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CSL.AU\",,,,,undefined,":{"symbol":"CSL.AU","floatShares":483950454,"roa":"6.58%","roe":"6.66%","lyrEps":8.740663,"volumeRatio":1.046357,"shares":485151394,"dividePrice":4.136587,"high":154.1,"amplitude":0.021402,"preClose":154.19,"low":150.8,"week52Low":149.85,"pbRate":"2.81","psRate":"3.41","week52High":272.649,"institutionHeld":0,"latestPrice":153.27,"committee":0.501779,"eps":4.048689891995421,"divideRate":0.026989,"volume":1455538,"delay":0,"ttmEps":4.048689891995421,"open":152.55,"prevYearClose":172.65,"prevWeekClose":150.01,"prevMonthClose":181.42,"prevQuarterClose":172.65,"fiveDayClose":150.01,"twentyDayClose":178.41,"sixtyDayClose":182.95,"dividendPayoutRate":0.4488044711953849,"dividendGrowthYears":4,"dividendGrowthRate":0.11620984529927163,"fiveYearAvgDividendRate":0.013182154300910737},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CSL.AU\",params:#limit:5,,,undefined,":[{"date":"2026-03-10","symbol":"CSL.AU","amount":1.3,"announcedDate":"2026-02-11","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-03-11","defaultRemindTime":1773097200000,"name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-04-09","payableDate":"2026-03-11","currency":"USD","dateTimestamp":1773061200000,"payDate":"2026-04-09"},{"date":"2026-02-11","symbol":"CSL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1770764400000,"name":null,"time":"","dateTimestamp":1770728400000,"actualEps":null},{"date":"2025-09-09","symbol":"CSL.AU","amount":1.62,"announcedDate":"2025-08-19","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-09-10","defaultRemindTime":1757376000000,"name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-10-03","payableDate":"2025-09-10","currency":"USD","dateTimestamp":1757340000000,"payDate":"2025-10-03"},{"date":"2025-08-19","symbol":"CSL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755561600000,"name":null,"time":"","dateTimestamp":1755525600000,"actualEps":null},{"date":"2025-03-10","symbol":"CSL.AU","amount":1.3,"announcedDate":"2025-02-11","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-03-11","name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-09","payableDate":"2025-03-11","currency":"USD","dateTimestamp":1741525200000,"payDate":"2025-04-09"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CSL.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2020-09-10","recordDate":"2020-09-11","paymentDate":"2020-10-09","value":1.469578,"currency":"AUD"},{"executeDate":"2021-03-04","recordDate":"2021-03-05","paymentDate":"2021-04-01","value":1.04,"currency":"USD"},{"executeDate":"2021-09-02","recordDate":"2021-09-03","paymentDate":"2021-09-30","value":1.062,"currency":"USD"},{"executeDate":"2022-03-07","recordDate":"2022-03-08","paymentDate":"2022-04-06","value":1.04,"currency":"USD"},{"executeDate":"2022-09-06","recordDate":"2022-09-07","paymentDate":"2022-10-05","value":1.062,"currency":"USD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CSL.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2612947955","title":"CSL Ltd-Change of Director's Interest Notice","url":"https://stock-news.laohu8.com/highlight/detail?id=2612947955","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612947955?lang=en_us&edition=fundamental","pubTime":"2026-02-19 11:43","pubTimestamp":1771472595,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260219:nTUE4LM7YQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","BK7511","BK7501","CSL.AU","BK7508"],"gpt_icon":0},{"id":"2612491120","title":"BUZZ-Australia's CSL recovers after signing licensing deal with Eli Lilly","url":"https://stock-news.laohu8.com/highlight/detail?id=2612491120","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612491120?lang=en_us&edition=fundamental","pubTime":"2026-02-18 08:32","pubTimestamp":1771374761,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's CSL recovers after signing licensing deal with Eli Lilly** Shares of CSL CSL.AX rise 1.5% to A$153.78** Shares rebound after plunging 16.9% last week on posting an 81% drop in firsthalf profit, while CEO Paul McKenzie stepped down** Australian biotech giant signs licensing agreement with Eli Lilly LLY.N, granting it certain rights to develop and commercialise clazakizumab** Clazakizumab is an antibody aimed at preventing heart-related illness and death in people with endstage kidney disease** CSL will receive an upfront payment of $100 million** CSL shares down 10.9% YTD","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260218:nL6N3ZE00N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2552382215.SGD","LU2552382132.HKD","LU2063271972.USD","LU1629891620.HKD","LU0964807845.USD","IE0004445239.USD","LU1551013425.SGD","IE00BKPKM429.USD","LU0820561818.USD","IE00BWXC8680.SGD","LU0683600562.USD","SGXZ31699556.SGD","LU0094547139.USD","LU2462157665.USD","IE00BFSS8Q28.SGD","BK4585","LU0289739699.SGD","LU0471298694.HKD","LU2106854487.HKD","LU0689472784.USD","LU0672654240.SGD","SG9999015945.SGD","LU0882574055.USD","ELIL","LU2089984988.USD","LU0158827781.USD","LU1804176565.USD","LU2750360641.GBP","LU2168564222.USD","LU1868837136.USD","LU2491050154.USD","LU0471298777.SGD","LU0256863811.USD","LU2471134796.USD","BK4533","LU0353189763.USD","IE0009355771.USD","IE00B1XK9C88.USD","IE00BKDWB100.SGD","LU0385154629.USD","LU0786609619.USD","SG9999014898.SGD","SG9999001176.USD","LU1291159041.SGD","CSL.AU","LU1974910355.USD","LU1623119135.USD","LU0316494557.USD","IE00B1BXHZ80.USD","IE00BN29S564.USD","BK4007","LU0354030511.USD","SG9999018865.SGD","LU0823416689.USD","IE0005OL40V9.USD","LU2237443382.USD","SG9999014914.USD","LU1064131342.USD","IE00BJJMRZ35.SGD","LU1145028129.USD","LU2756315664.SGD","LU2468319806.SGD","LU0225283273.USD","LU2237443895.HKD","LU0466842654.USD","SG9999015986.USD","IE00BK4W5L77.USD","LU0210536198.USD","LU1712237335.SGD","SG9999015978.USD","IE00BJT1NW94.SGD","LU0266013472.USD","LU2111349929.HKD","LU2237443978.SGD","LU1280957306.USD","LU0106261372.USD","LU2756315318.SGD","LU1917777945.USD","LU2271345857.HKD","IE0004445015.USD","LU1127390331.HKD","LU2357305700.SGD","LU0114720955.EUR","LU0882574139.USD","LU1720051108.HKD","LU0320765059.SGD","LU2471134879.HKD","LU2461242641.AUD","BK7501","LU2023250330.USD","LU2361044865.SGD","IE00BJJMRX11.SGD","SG9999014906.USD","LU2456880835.USD","SG9999013999.USD","LU0109391861.USD","LU2213496289.HKD","LU1988902786.USD","LU2491050071.SGD","LU1868837300.USD","LU2361044949.HKD","LU0417517546.SGD","LU0256863902.USD","LU1069344957.HKD","SGXZ99366536.SGD","BK7067","LU0820561909.HKD","BK7508","LU0061475181.USD","LU1035775433.USD","SG9999017495.SGD","BK4599","LU2417539215.USD","LU2264538146.SGD","LU1323610961.USD","LU0353189680.USD","LU2108987350.USD","LU1267930730.SGD","LU2168564065.EUR","LLY","LU2360106947.USD","SG9999014880.SGD","LU2471134523.USD","SGXZ81514606.USD","IE00BJLML261.HKD","IE00B775H168.HKD","LU0889565916.HKD","LU2265009873.SGD","IE00BJJMRY28.SGD","BK4581","LU1814569148.SGD","LU2491049909.HKD","LU2746668974.SGD","IE00B2B36J28.USD","LU1057294990.SGD","LU1548497426.USD","IE00B4JS1V06.HKD","LU0820562030.AUD","IE0002141913.USD","LU1023059063.AUD","GB00BDT5M118.USD","LU0203201768.USD","LU2471134952.CNY","LU2168564149.EUR","LU2028103732.USD","LU2361045086.USD","LU2023251221.USD","LU2750360997.AUD","LU1093756168.USD","LU1868836914.USD","LU2089283258.USD","LU2746668461.USD","LU0238689110.USD","LU0158827948.USD","LU0943347566.SGD","IE00BK4W5M84.HKD","LU2211815571.USD","LU2236285917.USD","SGXZ57979304.SGD","LU0432979614.USD","LU1232071149.USD","LLYZ","LU1720051017.SGD","SG9999018857.SGD","BK7511","LU1093756325.SGD","LU0823434740.USD","LU0640476718.USD","BK4534","IE00B4R5TH58.HKD","LU2168564495.EUR","LU1989771016.USD","LU0354030438.USD","LU0097036916.USD","IE00BFSS7M15.SGD","LU2237443622.USD","SG9999001176.SGD","LLYX","LU2023250504.SGD","LU2602419157.SGD","LU2237443465.HKD","LU0096364046.USD","LU0006306889.USD","LU0109394709.USD","SG9999015952.SGD","LU1061106388.HKD","LU1868836757.USD","LU2552382058.USD","SGXZ51526630.SGD","LU2089284900.SGD","LU0323591593.USD","LU0787776722.HKD","IE00BFTCPJ56.SGD","LU2087625088.SGD","IE00B7KXQ091.USD","LU0058720904.USD","LU0708995401.HKD","LU1366192091.USD","LU0079474960.USD","LU0122379950.USD","LU2168563687.JPY","LU1868836591.USD","LU0456855351.SGD","LU2112291526.USD","ELIS","LU0198837287.USD","LU1983299246.USD","LU2237443549.SGD","BK4588","LU2896262040.SGD","BK4516","LU2324357040.USD","LU0234572021.USD","LU0203202063.USD","LU2237438978.USD","LU0823434583.USD","LU0320765992.SGD","LU1551013342.USD"],"gpt_icon":1},{"id":"2612498320","title":"BRIEF-CSL And Lilly Enter Licensing Agreement For Clazakizumab","url":"https://stock-news.laohu8.com/highlight/detail?id=2612498320","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612498320?lang=en_us&edition=fundamental","pubTime":"2026-02-18 05:19","pubTimestamp":1771363186,"startTime":"0","endTime":"0","summary":"BRIEF-CSL And Lilly Enter Licensing Agreement For ClazakizumabFeb 18 (Reuters) - CSL Ltd CSL.AX:CSL AND LILLY ENTER LICENSING AGREEMENT FOR CLAZAKIZUMABEXCLUSIVE LICENSING AGREEMENT GRANTING CERTAIN R","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260217:nFWN3ZD0DO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1127390331.HKD","LU1548497426.USD","LU0061475181.USD","LU0456855351.SGD","IE00BK4W5L77.USD","LU1989771016.USD","IE00B775H168.HKD","LU1974910355.USD","LU2471134952.CNY","LU0114720955.EUR","LU1983299246.USD","SG9999018865.SGD","LU2089283258.USD","LU2213496289.HKD","LU0354030438.USD","LU2168564065.EUR","IE00B1BXHZ80.USD","LU2023251221.USD","BK4516","LU2552382215.SGD","LU0882574139.USD","LU1868836591.USD","LU0432979614.USD","LU0943347566.SGD","LU1551013342.USD","LU2491049909.HKD","SGXZ57979304.SGD","LU0471298777.SGD","LU1267930730.SGD","LU0823416689.USD","LU2471134523.USD","LU2471134879.HKD","SGXZ51526630.SGD","LU2756315664.SGD","IE00BFSS8Q28.SGD","LU1868836914.USD","LU2168564222.USD","IE00BWXC8680.SGD","LU0158827781.USD","LU1323610961.USD","LU0820562030.AUD","LU2237443465.HKD","LU1366192091.USD","LU0203201768.USD","SGXZ99366536.SGD","IE00BKPKM429.USD","LU0006306889.USD","LU2462157665.USD","LU0058720904.USD","LU0109391861.USD","LU2237438978.USD","BK7067","LU2750360641.GBP","IE00B2B36J28.USD","LU2023250504.SGD","LU1720051017.SGD","LU0786609619.USD","SG9999018857.SGD","LU0210536198.USD","LU0289739699.SGD","LU2360106947.USD","SG9999014880.SGD","LU0094547139.USD","LU0106261372.USD","LU2089284900.SGD","LU2361044949.HKD","LU2417539215.USD","LU2357305700.SGD","LU2265009873.SGD","IE0005OL40V9.USD","LU0079474960.USD","LU1814569148.SGD","LU1868837136.USD","LU2237443549.SGD","LU0234572021.USD","SGXZ81514606.USD","LU0225283273.USD","LU1623119135.USD","IE00B1XK9C88.USD","LU2089984988.USD","IE00BJJMRZ35.SGD","SG9999013999.USD","IE00BFSS7M15.SGD","LU0320765059.SGD","LU2168564495.EUR","LU2211815571.USD","LU2456880835.USD","BK4585","IE0004445239.USD","LU0238689110.USD","LU2106854487.HKD","LU2361045086.USD","SGXZ31699556.SGD","LU2236285917.USD","LU1291159041.SGD","IE00BJT1NW94.SGD","LU0109394709.USD","IE0009355771.USD","LU2237443382.USD","LU0708995401.HKD","LU2491050071.SGD","IE00BKDWB100.SGD","LU0320765992.SGD","BK4581","BK7511","LU2552382132.HKD","LU2746668461.USD","LU0820561818.USD","BK7508","LU0122379950.USD","SG9999015986.USD","IE0002141913.USD","IE00BJJMRX11.SGD","LU0203202063.USD","LU1093756325.SGD","BK4534","LU0353189763.USD","LU1551013425.SGD","ELIL","LU2112291526.USD","LU1093756168.USD","LU2087625088.SGD","LU0823434740.USD","LU1868836757.USD","LU0353189680.USD","LU1232071149.USD","SG9999001176.SGD","BK4588","LU1804176565.USD","LU1868837300.USD","LU2461242641.AUD","LU2361044865.SGD","IE00BFTCPJ56.SGD","LU2168563687.JPY","LU1720051108.HKD","BK7501","LU1145028129.USD","LU2111349929.HKD","SG9999015952.SGD","LU0417517546.SGD","SG9999014898.SGD","LU0256863811.USD","SG9999014914.USD","LU0097036916.USD","LU2750360997.AUD","SG9999014906.USD","SG9999017495.SGD","LU2324357040.USD","SG9999015945.SGD","LLY","IE00B7KXQ091.USD","LU2896262040.SGD","LLYZ","LU1064131342.USD","IE00B4R5TH58.HKD","LU1061106388.HKD","CSL.AU","IE00B4JS1V06.HKD","LU0683600562.USD","LU2168564149.EUR","LU0672654240.SGD","LU1280957306.USD","LU2237443978.SGD","BK4007","LU1917777945.USD","LU0354030511.USD","LU0787776722.HKD","SG9999001176.USD","LU2552382058.USD","BK4533","LU0266013472.USD","LU0466842654.USD","LU2602419157.SGD","LU1057294990.SGD","SG9999015978.USD","LU1629891620.HKD","LU1023059063.AUD","LU1712237335.SGD","IE00BK4W5M84.HKD","LU0316494557.USD","LU2028103732.USD","LU1035775433.USD","LU2023250330.USD","LU2756315318.SGD","LU2237443622.USD","LU2108987350.USD","LU2271345857.HKD","IE00BJJMRY28.SGD","LU2746668974.SGD","LU0323591593.USD","LU1988902786.USD","LU0256863902.USD","LU2264538146.SGD","LU2237443895.HKD","LU0964807845.USD","LU2491050154.USD","LU2468319806.SGD","LU0471298694.HKD","LU0198837287.USD","LU0823434583.USD","LU0096364046.USD","LU0882574055.USD","GB00BDT5M118.USD","BK4599","LU0385154629.USD","LU0689472784.USD","LLYX","LU0820561909.HKD","LU0889565916.HKD","LU0640476718.USD","LU1069344957.HKD","LU2063271972.USD","IE0004445015.USD","LU0158827948.USD","LU2471134796.USD","ELIS","IE00BJLML261.HKD","IE00BN29S564.USD"],"gpt_icon":1},{"id":"2612460444","title":"CSL Ltd -  CSL Will Receive an Upfront Payment of $100 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2612460444","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612460444?lang=en_us&edition=fundamental","pubTime":"2026-02-18 05:13","pubTimestamp":1771362816,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260217:nFWN3ZD0DO:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","BK7508","BK7501","BK7511","CSL.AU"],"gpt_icon":0},{"id":"2612415460","title":"CSL Ltd - Exclusive Licensing Agreement Granting Certain Rights to Develop and Commercialise Clazakizumab","url":"https://stock-news.laohu8.com/highlight/detail?id=2612415460","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612415460?lang=en_us&edition=fundamental","pubTime":"2026-02-18 05:13","pubTimestamp":1771362816,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260217:nFWN3ZD0DO:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7067","CSL.AU","BK7501","BK7511"],"gpt_icon":0},{"id":"2612133431","title":"CSL's (ASX:CSL) Soft Earnings Are Actually Better Than They Appear","url":"https://stock-news.laohu8.com/highlight/detail?id=2612133431","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612133431?lang=en_us&edition=fundamental","pubTime":"2026-02-17 12:22","pubTimestamp":1771302122,"startTime":"0","endTime":"0","summary":"Investors were disappointed with the weak earnings posted by CSL Limited ( ASX:CSL ). While the headline numbers were...","market":"hk","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/csls-asxcsl-soft-earnings-are-actually-better-than-they-appe","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/csls-asxcsl-soft-earnings-are-actually-better-than-they-appe","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["CSL","CSL.AU"],"gpt_icon":0},{"id":"2611179937","title":"CSL Limited Receives Australian Approval for Neffy Adrenaline Nasal Spray","url":"https://stock-news.laohu8.com/highlight/detail?id=2611179937","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611179937?lang=en_us&edition=fundamental","pubTime":"2026-02-16 07:01","pubTimestamp":1771196498,"startTime":"0","endTime":"0","summary":"CSL Seqirus, a subsidiary of CSL Limited, has announced that neffy adrenaline  nasal spray has been approved for use in Australia for the emergency treatment of anaphylaxis in adults and children weighing 15kg or more and aged four years and over. CSL has also submitted an application for neffy to be subsidised and listed on the Pharmaceutical Benefits Scheme, with the submission to be considered in March 2026. Neffy is currently not listed on the Pharmaceutical Benefits Scheme.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CSL Limited published the original content used to generate this news brief on February 15, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260215:nNDL1zdjBD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7511","BK7501","CSL.AU","BK7067","BK7508"],"gpt_icon":0},{"id":"2611799321","title":"CSL Ltd - Neffy, Adrenaline Nasal Spray, NOW Approved to Treat Anaphylaxis in Australia","url":"https://stock-news.laohu8.com/highlight/detail?id=2611799321","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611799321?lang=en_us&edition=fundamental","pubTime":"2026-02-16 07:01","pubTimestamp":1771196462,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260215:nFWN3ZB03B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7511","BK7501","CSL.AU","BK7067","BK7508"],"gpt_icon":0},{"id":"2611726116","title":"CSL (ASX:CSL) Is Down 16.9% After CEO Exit And Profit Hit Has The Bull Case Changed?","url":"https://stock-news.laohu8.com/highlight/detail?id=2611726116","media":"Simply Wall St.","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611726116?lang=en_us&edition=fundamental","pubTime":"2026-02-14 13:30","pubTimestamp":1771047014,"startTime":"0","endTime":"0","summary":"In February 2026, CSL Limited reported half-year revenue of US$8,332 million and net income of US$401 million, announced an estimated interim dividend of US$1.30 per share, and confirmed the abrupt retirement of CEO and Managing Director Paul McKenzie with long-time executive Gordon Naylor stepping in as interim leader.\nThe sharp fall in net profit, driven by one-off costs and impairments, combined with a sudden leadership change, raises fresh questions about how CSL’s ongoing transformation...","market":"hk","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/csl-asxcsl-is-down-169-after-ceo-exit-and-profit-hit-has-the","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/csl-asxcsl-is-down-169-after-ceo-exit-and-profit-hit-has-the","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SG9999004303.SGD","LU0728928796.USD","BK4086","BK7511","BK7508","BK7067","CSL.AU","CSL","SGXZ23171101.USD","BK7501","LU1169589451.USD","LU1169590202.USD"],"gpt_icon":0},{"id":"2611189608","title":"CSL (ASX:CSL) Valuation After Profit Slump CEO Exit And Expanded Share Buyback Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2611189608","media":"Simply Wall St.","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611189608?lang=en_us&edition=fundamental","pubTime":"2026-02-13 09:33","pubTimestamp":1770946401,"startTime":"0","endTime":"0","summary":"Why CSL (ASX:CSL) is in focus right now\nCSL (ASX:CSL) is back in the spotlight after reporting an 81% drop in first half net profit, confirming its interim dividend, expanding its share buyback program, and announcing the sudden retirement of CEO Paul McKenzie.\nSee our latest analysis for CSL.\nThose profit and leadership shocks have gone hand in hand with sharp share price moves, with a 1 day share price return of 6.88% decline and a 7 day share price return of 16.03% decline. The 1 year...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/csl-asxcsl-valuation-after-profit-slump-ceo-exit-and-expande","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/csl-asxcsl-valuation-after-profit-slump-ceo-exit-and-expande","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SG9999004303.SGD","CSL.AU","LU1169589451.USD","BK7067","LU1169590202.USD","BK4086","CSL","LU0728928796.USD","SGXZ23171101.USD","BK7508","BK7501","BK7511"],"gpt_icon":0},{"id":"2611907507","title":"Weekly Earnings Wrap: CBA, CSL, MQG and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2611907507","media":"Morning Star AU","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611907507?lang=en_us&edition=fundamental","pubTime":"2026-02-13 00:00","pubTimestamp":1770912000,"startTime":"0","endTime":"0","summary":"This is our second edition of the weekly wrap for the February 2026 earnings season. This week of earnings was packed with many ASX heavyweights reporting interim or quarterly results. Among those inc","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"morningstar_stock","url":"https://www.morningstar.com.au/stocks/weekly-earnings-wrap-cba-csl-mqg-more","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.morningstar.com.au/stocks/weekly-earnings-wrap-cba-csl-mqg-more","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"morningstar_stock","symbols":["CSL.AU","CSL","CBA.AU"],"gpt_icon":0},{"id":"2610995250","title":"BUZZ-CSL rout extends into sixth session after CEO departure, weak earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2610995250","media":"Reuters","labels":["executive","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610995250?lang=en_us&edition=fundamental","pubTime":"2026-02-12 09:26","pubTimestamp":1770859599,"startTime":"0","endTime":"0","summary":"BUZZ-CSL rout extends into sixth session after CEO departure, weak earnings** Shares of CSL Ltd CSL.AX fall 7.8% to A$150.660, extending losses into their sixth consecutive session** Stock is down 15% for the week, with most of the losses coming since Wednesday, after CEO Paul McKenzie announced retirement** If the trend holds, CSL would post its worst week since late October** CSL on Wednesday also reported an 81% drop in its first-half profit, hurt by weaker plasma and vaccine sales and one-off charges** CSL stock, once the priciest in Australia, is down 43% since August, when it first announced the spinoff of its influenza vaccine division, Seqirus, and flagged a broader restructuring** CSL stock's relative strength index  dipped below 30 on Wednesday for the first time since early November — a threshold market participants consider indicative of being oversold** CSL stock down 11.6% this year, including the day's move","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260212:nL4N3Z8048:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"executive,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","BK7501","BK7511","BK7508","CSL.AU"],"gpt_icon":0},{"id":"1150944258","title":"Stock Track | CSL Plummets 7.73% Intraday on Margin Compression and Earnings Concerns","url":"https://stock-news.laohu8.com/highlight/detail?id=1150944258","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150944258?lang=en_us&edition=fundamental","pubTime":"2026-02-12 08:34","pubTimestamp":1770856485,"startTime":"0","endTime":"0","summary":"CSL LIMITED (CSL.AU) saw its shares plummet 7.73% during intraday trading on Thursday, marking a significant decline for the biopharmaceutical heavyweight.The sharp drop follows the release of the...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["CSL.AU"],"gpt_icon":0},{"id":"2610129993","title":"Analysts Are Bullish on These Healthcare Stocks: Viking Therapeutics (VKTX), CSL (CMXHF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2610129993","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610129993?lang=en_us&edition=fundamental","pubTime":"2026-02-12 08:30","pubTimestamp":1770856208,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Viking Therapeutics (VKTX – Research Report) and CSL...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-viking-therapeutics-vktx-csl-cmxhf-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-viking-therapeutics-vktx-csl-cmxhf-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SG9999004303.SGD","CSL.AU","BK4599","BK4112","LU0029874061.USD","XBI","BK4581","LU1169590202.USD","LU1169589451.USD","BLSX","BK4585","LABU","LU0128526141.USD","BK4139","BK4137","VKTX","BK4086","LU0728928796.USD","BLSG","BK4588","SGXZ23171101.USD"],"gpt_icon":0},{"id":"2610826993","title":"CSL (ASX:CSL) Trailing Net Margin Compression Tests Bullish Growth Narratives","url":"https://stock-news.laohu8.com/highlight/detail?id=2610826993","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610826993?lang=en_us&edition=fundamental","pubTime":"2026-02-12 04:23","pubTimestamp":1770841384,"startTime":"0","endTime":"0","summary":"CSL (ASX:CSL) has put out its H1 2026 numbers with the latest trailing 12 month snapshot showing revenue of about US$15.4b and basic EPS of US$2.89, while headline metrics for the last reported half year include H2 2025 revenue of US$7.1b and basic EPS of US$2.05. Over recent periods, the company has seen revenue move from US$6.7b in H2 2024 to US$8.5b in H1 2025 and then US$7.1b in H2 2025, alongside EPS shifting from US$1.53 to US$4.15 and then US$2.05. This sets a mixed earnings tape that...","market":"hk","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/csl-asxcsl-trailing-net-margin-compression-tests-bullish-gro","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/csl-asxcsl-trailing-net-margin-compression-tests-bullish-gro","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7508","LU0728928796.USD","SGXZ23171101.USD","LU1169590202.USD","CSL.AU","BK7511","LU1169589451.USD","BK7067","BK4112","BLSG","SG9999004303.SGD","BK4086","BK7501","BLSX"],"gpt_icon":0},{"id":"2610953401","title":"GLOBAL MARKETS-Stocks, dollar jump after US jobs data beat; AI worries simmer below the surface","url":"https://stock-news.laohu8.com/highlight/detail?id=2610953401","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610953401?lang=en_us&edition=fundamental","pubTime":"2026-02-11 22:04","pubTimestamp":1770818678,"startTime":"0","endTime":"0","summary":"GLOBAL MARKETS-Stocks, dollar jump after US jobs data beat; AI worries simmer below the surfaceUpdates throughoutUS economy adds 130,000 jobs, exceeding expectationsAI concerns impact European asset managers, STOXX 600 still hits record highsYen strengthens post-Takaichi's election win, defying stimulus concerns","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260211:nL1N3Z70MY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7501","BK7067","BK7511","CSL.AU"],"gpt_icon":0},{"id":"2610983995","title":"Australian shares reclaim 9,000 mark as banks rally on CBA results","url":"https://stock-news.laohu8.com/highlight/detail?id=2610983995","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610983995?lang=en_us&edition=fundamental","pubTime":"2026-02-11 14:34","pubTimestamp":1770791642,"startTime":"0","endTime":"0","summary":"Australian shares reclaim 9,000 mark as banks rally on CBA resultsCBA up 6.8%Domino's Pizza Enterprises jump 2.9%AGL Energy up 11.8%Healthcare stocks log lowest level since mid-May 2019By Anjali  Singh","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260211:nL6N3Z705K:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0726765562.USD","LU1074936037.SGD","IE00BJTD4N35.SGD","LU2279689827.SGD","LU0795875169.SGD","CBA.AU","BK4610","IE00BJJMRY28.SGD","BK7501","LU0417517546.SGD","LU2133065610.SGD","LU0868494708.USD","IE0004445015.USD","IE00BJJMRX11.SGD","BK7508","MCD","DMP.AU","BK4581","BK4588","LU1718418525.SGD","LU1585245621.USD","LU0912757837.SGD","AN3PL.AU","LU1244550494.USD","IE00BFSS7M15.SGD","LU1732799900.SGD","LU1244550577.SGD","NAB.AU","LU0795875086.SGD","IE00BFSS8Q28.SGD","LU1732800096.USD","BK7136","BK4534","AGL.AU","ANZ.AU","LU1430594728.SGD","BK4585","CSL.AU","BK7135","BK7067","BK4550","LU0256863811.USD","BK7137","LU0868494617.USD","LU1035773651.USD","LU1244550221.USD","WBC.AU","BK4504","LU2347655156.SGD","LU0942090050.USD"],"gpt_icon":0},{"id":"2610698834","title":"GLOBAL MARKETS-Buoyant stocks pause for breath; yen gallops higher","url":"https://stock-news.laohu8.com/highlight/detail?id=2610698834","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610698834?lang=en_us&edition=fundamental","pubTime":"2026-02-11 14:02","pubTimestamp":1770789744,"startTime":"0","endTime":"0","summary":"GLOBAL MARKETS-Buoyant stocks pause for breath; yen gallops higherYen up 2.5% vs dollar since Japan electionCBA up; CSL dives as Aussie results season kicks offS&P 500 futures steady; US jobs data awaitedUpdates to Asia afternoonBy Tom Westbrook. SINGAPORE, Feb 11  - Bonds gained and a rebound in stock markets slowed down on Wednesday after softer-than-expected U.S. retail sales figures, while a rally in the yen has extended and might be beginning to signal a shift in investor thinking since Japan's election.U.S. jobs figures are due later in the day and the chance of downward revisions to recent numbers have pressured the dollar.Trade in Asia was lightened by a holiday in Japan, but a third straight session of gains for the yen JPY= had it at 153.3 per dollar and set traders talking about whether it was catching a boost from Tokyo or riding high on dollar softness.It is up about 2.5% on the dollar since Prime Minister Sanae Takaichi won a sweeping victory in Sunday's election, confoun","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260211:nL1N3Z704U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","CBA.AU","BK7501","CSL.AU","BK7511","BK7508","BK7135"],"gpt_icon":0},{"id":"2610601753","title":"CSL's Fiscal H1 EBIT Boosted by Cost Reductions, Jarden Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2610601753","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610601753?lang=en_us&edition=fundamental","pubTime":"2026-02-11 11:39","pubTimestamp":1770781183,"startTime":"0","endTime":"0","summary":"CSL's  fiscal first-half earnings before interest and taxes  were boosted by big reductions in research and development as well as and general and administrative expenses, meeting expectations, Jarden said in a note on Wednesday.The company reported fiscal first-half underlying earnings of $4.03 per share, down from $4.29 a year earlier. Revenue for the six months ended Dec. 31, 2025, was $8.33 billion, compared with $8.48 billion a year earlier.The company maintained its fiscal 2026 guidance of a 2% to 3% growth in revenue and a 4% to 7% growth in net profit after tax and amortization.Fears around big downgrades were heightened after the surprise forced retirement of Chief Executive Paul McKenzie before the company reaffirmed guidance.There are good reasons to expect a recovery in IG and Albumin in the second fiscal half with Medicare Part D funding impact now in base and new Albumin distribution agreement starting.The investment firm reaffirmed an overweight rating with a price targe","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CSL","BK7511","LU0728928796.USD","BK4086","LU1169590202.USD","BK7501","EBIT","CSL.AU","SGXZ23171101.USD","BK7067","BK7508","SG9999004303.SGD","LU1169589451.USD"],"gpt_icon":0},{"id":"2610606258","title":"ASX Midday Sector Update: Financial Shares Jump, Healthcare Shares Fall","url":"https://stock-news.laohu8.com/highlight/detail?id=2610606258","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610606258?lang=en_us&edition=fundamental","pubTime":"2026-02-11 10:25","pubTimestamp":1770776757,"startTime":"0","endTime":"0","summary":"Shares of financial firms jumped nearly 4% at midday Wednesday, boosted by earnings from the country's largest bank.Commonwealth Bank of Australia  reported fiscal first-half cash earnings of AU$3.252 per share, up from AU$3.065 a year earlier.The Bank also said an independent review confirmed that the outcomes achieved through its Prudential Inquiry Remedial Action Plan have been sustained.On the flip side, the healthcare sector fell 3%.CSL  reported Wednesday fiscal first-half underlying earnings of $4.03 per share, down from $4.29 a year earlier.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7135","BK4585","BK4137","BK7511","CBA.AU","BK7508","LABU","BK4588","BK7501","CSL.AU","LU0029874061.USD","XLV","LU0128526141.USD","BK7067","BK4581","XBI","HCSG"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":199,"code":"91000000","status":"200"}]}}